Absorption, Distribution, Metabolism, and Excretion of Tirzepatide in Humans, Rats, and Monkeys.
Tirzepatide 在人類、老鼠和猴子中的吸收、分佈、代謝和排泄。
Eur J Pharm Sci 2024-09-07
A Phase 1 Multiple Dose Study of Tirzepatide in Chinese Patients with Type 2 Diabetes.
一項關於 Tirzepatide 在中國第二型糖尿病患者中的多劑量 Phase 1 研究。
Adv Ther 2023-08-22
Tirzepatide Immunogenicity on Pharmacokinetics, Efficacy, and Safety: Analysis of Data From Phase 3 Studies.
Tirzepatide 免疫原性對藥物動力學、療效和安全性的影響:來自第3期研究數據的分析。
J Clin Endocrinol Metab 2024-02-02
Effect on Hemoglobin A1c (HbA1c) and Body Weight After Discontinuation of Tirzepatide, a Novel Glucose-Dependent Insulinotropic Peptide (GIP) and Glucagon-Like Peptide-1 (GLP-1) Receptor Agonist: A Single-Center Case Series Study.
停用新型葡萄糖依賴性胰島素促分泌肽(GIP)和葡萄糖樣肽-1(GLP-1)受體激動劑 Tirzepatide 後對血紅蛋白A1c(HbA1c)和體重的影響:單一中心病例系列研究。
Cureus 2023-10-26
The preclinical discovery and clinical evaluation of tirzepatide for the treatment of type 2 diabetes.
Tirzepatide用於治療2型糖尿病的臨床前發現和臨床評估。
Expert Opin Drug Discov 2024-05-09
Evaluating the Efficacy and Safety of Tirzepatide on Glycaemic and Non-glycaemic Outcomes in Diabetes: A Systematic Review of Meta-Analyses.
評估 Tirzepatide 在糖尿病患者中對血糖和非血糖結果的療效和安全性:對 Meta 分析的系統性回顧。
Cureus 2024-04-27
Tirzepatide Reduces Fat Mass and Provides Good Glycaemic Control in Type 2 Diabetes Patients Undergoing Haemodialysis: A Single-Centre Retrospective Study.
Tirzepatide 在進行血液透析的第2型糖尿病患者中減少脂肪質量並提供良好的血糖控制:單中心回顧性研究。
Endocrinol Diabetes Metab 2024-05-11
Tirzepatide modulates the regulation of adipocyte nutrient metabolism through long-acting activation of the GIP receptor.
Tirzepatide透過長效活化腸骨肽激素受體,調節脂肪細胞營養代謝的調控。
Cell Metab 2024-06-15
Clinical Outcomes of Tirzepatide or GLP-1 Receptor Agonists in Individuals With Type 2 Diabetes.
Tirzepatide 或 GLP-1 受體激動劑在 2 型糖尿病患者中的臨床結果。
JAMA Netw Open 2024-08-12
Real-world evaluation of the effects of tirzepatide in patients with type 2 diabetes mellitus.
在真實世界中評估 tirzepatide 對 2 型糖尿病患者的影響。
Diabetes Obes Metab 2024-09-09